Exclusion Criteria:~* Any disability that could have prevented the participants from completing all study
requirements. -~* Current medical or neurological condition that could have impacted cognition or performance
on cognitive assessments.~* Advanced, severe progressive or unstable disease that could have interfered with
the safety, tolerability and study assessments, or put the participant at special risk.~* History of malignancy
of any organ system, treated or untreated, within the past 60 months.~* Indication for, or current treatment
with ChEIs and/or another AD treatment (e.g. memantine).~* Contraindication or intolerance to MRI.~* Brain MRI
results showing findings unrelated to AD that, in the opinion of the Investigator might be a leading cause to
future cognitive decline, could have posed a risk to the participant, or could have prevented a satisfactory
MRI assessment for safety monitoring.~* Suicidal Ideation in the past six months, or Suicidal Behavior in the
past two years.~* A positive drug screen at Screening, if, in the Investigator's opinion, was is due to drug
abuse.~* Significantly abnormal laboratory results at Screening, not as a result of a temporary condition.~*
Current clinically significant ECG findings.~* Clinically relevant depigmenting or hypopigmenting conditions
(e.g. albinism, vitiligo) or active / history of chronic urticaria in the past year.
